Specialists in Infusion Therapy

Christen A. Alevizatos, M.D., F.A.C.S.
Curriculum Vitae

Christen A. Alevizatos, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • Washington and Lee University, B.A., B.S.
  • Vanderbilt University Medical School, M.D.
  • University of Pittsburgh Medical Center Urology Residency

Dr. Alevizatos has been practicing urology in Baltimore for more than 10 years. His urologic interests include erectile dysfunction and prosthetic surgery, open and laparoscopic management of renal malignancies, benign prostatic hyperplasia (BPH), and stone disease.


He has served on the Surgical Quality Assurance, Cancer, and Medical Executive Committees at Good Samaritan Hospital and has served as the Physician Liaison for the Prostate Cancer Support Group.


David S. Goldstein, M.D., F.A.C.S.
Curriculum Vitae

David S. Goldstein, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • Boston University, B.S.
  • Mount Sinai School of Medicine, M.D.
  • Harvard Medical School Urology Residency Program

Dr. Goldstein has been involved in several research studies involving pharmacological and medical device testing. His clinical areas of interest are minimally invasive surgery for prostate, kidney and bladder cancers, including robotic and laparoscopic surgery; the treatment of kidney stones; and female and male incontinence.


Benjamin H. Lowentritt, M.D., F.A.C.S.
Curriculum Vitae

Benjamin H. Lowentritt, M.D., F.A.C.S.

American Board of Urology;
Fellow of the American College of Surgeons

  • Director, Minimally Invasive Surgery and Robotics, Chesapeake Urology Associates
  • Harvard College, A.B., History of Science, Magna Cum Laude
  • Baylor College of Medicine, M.D.
  • University of Maryland Medical System General Surgery Residency
  • University of Maryland Medical System Urology Residency
  • Tulane University Medical Center Fellowship in robotic, laparoscopic, and advanced endoscopic urology

  • Director, Minimally Invasive Surgery and Robotics, Chesapeake Urology Associates

  • Director, Prostate Cancer Care Program, Chesapeake Urology Associates

  • Past President, Baltimore City Medical Society



Dr. Lowentritt has a general urology practice with a focus on minimally invasive techniques to treat urological conditions. His expertise includes robotic, laparoscopic, and endoscopic management of renal, bladder, and prostate cancer, as well as minimally invasive options for benign prostatic hyperplasia (BPH), kidney stones, pelvic organ prolapse, and ureteropelvic junction obstruction. 


Dr. Lowentritt has been at the forefront of robotic urology procedures and was the first surgeon in Maryland to perform robot assisted surgery for bladder cancer. 


He has authored numerous articles and chapters on subjects including robotic surgery, erectile dysfunction, pediatric urology, female urology and the urological management of patients after renal transplantation.


Dr. Lowentritt has been selected as a "Super Doctor" by his peers in The Washington Post magazine and as a "Top Doctor" in Baltimore magazine. Dr. Lowentritt serves on the Board of Directors for the Baltimore City Medical Society.


 


Ronald F. Tutrone, Jr., M.D., F.A.C.S., C.P.I.
Curriculum Vitae

Ronald F. Tutrone, Jr., M.D., F.A.C.S., C.P.I.

American Board of Urology;
Fellow of the American College of Surgeons


  • Chief, Division of Urology, Greater Baltimore Medical Center

  • Medical Director, Chesapeake Urology Research Associates


 


Dr. Tutrone's clinical interests include treatment of urologic malignancies including kidney, bladder and prostate; laparoscopic treatment of renal and adrenal tumors; kidney stone treatment; urinary incontinence in men and women; and prostate disorders.


He has been voted a "Top Doctor" by Baltimore magazine six times, and a "Super Doctor" for Urology in the Washington Post Magazine Washington, DC, Northern Virginia and Baltimore.


Dr. Tutrone has authored numerous articles in the urology literature. He has been principal investigator in more than 200 clinical research trials. He Chairman of the William E. Kalhert Endowment for Urological Research and Medical Director, of Chesapeake Urology Research Associates.